ask="1.36"
ask_size="7000"
average_daily_volume="1389840"
bid="1.28"
bid_size="2500"
book_value="0.61"
change="+0.02"
change_from_200_day_moving_average="0.37"
change_from_50_day_moving_average="0.26"
change_from_52_week_high="-3.00"
change_From_52_week_low="0.70"
change_in_percent="+1.53%"
close="1.33"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.65"
ebitda="-42.12M"
eps_estimate_current_year="-1.50"
eps_estimate_next_quarter="-0.31"
eps_estimate_next_year="-1.45"
ex_dividend_date="N/A"
float_shares="18031000"
high="1.38"
high_52_weeks="4.33"
last_trade_date="3/1/2017"
last_trade_price="1.33"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="1.29"
low_52_weeks="0.63"
market_capitalization="36.49M"
moving_average_200_day="0.96"
moving_average_50_day="1.07"
name="Cerulean Pharma Inc."
notes="N/A"
one_year_target_price="5.50"
open="1.36"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+38.07%"
percent_change_from_50_day_moving_average="+24.57%"
percent_change_from_52_week_high="-69.28%"
percent_change_from_52_week_low="+111.01%"
previous_close="1.31"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.16"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="27435000"
short_ratio="2.51"
stock_exchange="NGM"
symbol="CERU"
volume="594801"
weeks_range_52="0.63 - 4.33"
